Wedgewood Pharmacy, a leading compounding pharmacy for veterinary medicine, has recently announced its merger with Blue Rabbit, a veterinary platform that provides telemedicine and other digital services to veterinarians and pet owners. The merger is backed by Partners Group, a global private markets investment manager.
The merger is expected to create a comprehensive platform that will offer a wide range of services to veterinarians and pet owners. Wedgewood Pharmacy has been a trusted name in the veterinary industry for over 40 years, providing customized medications for pets that are not available commercially. With the merger, Wedgewood Pharmacy will be able to expand its reach and offer its services to a wider audience.
Blue Rabbit, on the other hand, is a digital platform that provides telemedicine services to veterinarians and pet owners. The platform allows pet owners to connect with veterinarians remotely, enabling them to receive medical advice and treatment without having to visit a clinic. Blue Rabbit also offers other digital services such as online appointment scheduling and prescription refills.
The merger between Wedgewood Pharmacy and Blue Rabbit is expected to create a comprehensive platform that will offer a wide range of services to veterinarians and pet owners. The platform will combine Wedgewood Pharmacy’s expertise in compounding medications with Blue Rabbit’s digital services, creating a one-stop-shop for veterinary care.
Partners Group, the global private markets investment manager backing the merger, has a strong track record of investing in healthcare companies. The firm has invested in several healthcare companies in the past, including EyeCare Partners, a leading provider of optometry services in the US.
The merger between Wedgewood Pharmacy and Blue Rabbit is expected to be completed by the end of 2021. The new platform will be led by David Shaw, the CEO of Wedgewood Pharmacy. Shaw has over 30 years of experience in the pharmaceutical industry and is expected to bring his expertise to the new platform.
In conclusion, the merger between Wedgewood Pharmacy and Blue Rabbit is expected to create a comprehensive platform that will offer a wide range of services to veterinarians and pet owners. The platform will combine Wedgewood Pharmacy’s expertise in compounding medications with Blue Rabbit’s digital services, creating a one-stop-shop for veterinary care. The merger is backed by Partners Group, a global private markets investment manager with a strong track record of investing in healthcare companies. The new platform is expected to be led by David Shaw, the CEO of Wedgewood Pharmacy, and is expected to be completed by the end of 2021.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- EVM Finance. Unified Interface for Decentralized Finance. Access Here.
- Quantum Media Group. IR/PR Amplified. Access Here.
- PlatoAiStream. Web3 Data Intelligence. Knowledge Amplified. Access Here.
- Source: Plato Data Intelligence.
The Journey of Funds: From the Barrel to the Bank – Insights from PE Hub
The Journey of Funds: From the Barrel to the Bank – Insights from PE Hub Private equity (PE) has become...